We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$41.2B
AUM Growth
+$785M
Cap. Flow
-$197M
Cap. Flow %
-0.48%
Top 10 Hldgs %
16.49%
Holding
2,297
New
154
Increased
708
Reduced
1,158
Closed
139

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$171M
2
RF icon
Regions Financial
RF
+$151M
3
BABA icon
Alibaba
BABA
+$109M
4
KO icon
Coca-Cola
KO
+$75.9M
5
AMCR icon
Amcor
AMCR
+$67.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.02%
2 Technology 14.7%
3 Financials 10.86%
4 Consumer Staples 10.23%
5 Consumer Discretionary 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTN icon
151
Vail Resorts
MTN
$5.67B
$62.8M 0.15%
281,284
+21,873
+8% +$4.86M
SLAB icon
152
Silicon Laboratories
SLAB
$7.16B
$62.7M 0.15%
605,961
+1,905
+0.3% +$184K
EG icon
153
Everest Group
EG
$15.6B
$62.5M 0.15%
252,758
-8,366
-3% -$2.01M
BIIB icon
154
Biogen
BIIB
$30.7B
$62.2M 0.15%
265,898
+51,424
+24% +$11.9M
AMN icon
155
AMN Healthcare
AMN
$1.36B
$61.6M 0.15%
1,134,672
+41,460
+4% +$2.1M
BRO icon
156
Brown & Brown
BRO
$25B
$60.8M 0.15%
1,815,118
-25,220
-1% -$800K
WMT icon
157
Walmart Inc
WMT
$907B
$60.6M 0.15%
1,645,716
+21,021
+1% +$724K
VRTX icon
158
Vertex Pharmaceuticals
VRTX
$124B
$59.5M 0.14%
324,730
-3,680
-1% -$643K
GKOS icon
159
Glaukos
GKOS
$9.37B
$59.5M 0.14%
788,632
+11,244
+1% +$807K
AMGN icon
160
Amgen
AMGN
$210B
$59.4M 0.14%
322,532
+1,799
+0.6% +$322K
EW icon
161
Edwards Lifesciences
EW
$49.2B
$58.3M 0.14%
947,238
-90,303
-9% -$5.46M
WWD icon
162
Woodward
WWD
$24B
$58M 0.14%
512,449
+105,765
+26% +$11.3M
ZGNX
163
DELISTED
Zogenix, Inc.
ZGNX
$57.9M 0.14%
1,211,777
+180,400
+17% +$7.26M
CDNS icon
164
Cadence Design Systems
CDNS
$94.9B
$57.7M 0.14%
814,628
+603,741
+286% +$40.4M
TCOM icon
165
Trip.com Group
TCOM
$29.3B
$57.6M 0.14%
+1,561,558
New +$61.6M
MRVL icon
166
Marvell Technology
MRVL
$154B
$57.6M 0.14%
2,412,698
-4,485
-0.2% -$105K
ULTA icon
167
Ulta Beauty
ULTA
$22.1B
$57.5M 0.14%
165,729
-1,660
-1% -$574K
GPN icon
168
Global Payments
GPN
$24.1B
$57.3M 0.14%
357,675
-61,076
-15% -$9.08M
BIO icon
169
Bio-Rad Laboratories Class A
BIO
$8.78B
$56.8M 0.14%
181,641
-3,995
-2% -$1.2M
CMCSA icon
170
Comcast
CMCSA
$87.8B
$56.2M 0.14%
1,330,081
-464,622
-26% -$19.6M
AER icon
171
AerCap
AER
$24B
$56.2M 0.14%
1,080,339
-5,160
-0.5% -$253K
TER icon
172
Teradyne
TER
$53.2B
$55.7M 0.14%
1,161,863
-216,863
-16% -$9.84M
F icon
173
Ford
F
$61.9B
$55.4M 0.13%
5,418,282
-23,088
-0.4% -$228K
WB icon
174
Weibo
WB
$1.98B
$54.9M 0.13%
1,260,044
-883,918
-41% -$49.6M
CB icon
175
Chubb
CB
$140B
$54.5M 0.13%
369,857
+9,526
+3% +$1.38M

Similar funds

Federated Hermes's Q2 2019 Portfolio in Review

As of Q2 2019, Federated Hermes held 2,297 positions worth $41.2B, up 1.9% from $40.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Federated Hermes's Q2 2019 filing shows 154 new, 708 increased, 1,158 reduced and 139 closed positions. Its largest new stake was Amcor: 1,210,171 shares worth $69.5M. The largest sale was American Electric Power, an estimated $183M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Federated Hermes's largest Q2 2019 buy was Amcor: 1,210,171 shares worth $69.5M.
  • Federated Hermes added most to Pfizer in Q2 2019, an estimated $171M increase.
  • Federated Hermes's biggest Q2 2019 reduction was American Electric Power, cutting an estimated $183M.
  • Federated Hermes fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
  • Federated Hermes's ten largest holdings make up 16% of its $41.2B portfolio in Q2 2019.
  • Federated Hermes opened 154 new positions and closed 139 in Q2 2019.
  • Federated Hermes's portfolio value rose 1.9% quarter-over-quarter to $41.2B.

Based on Federated Hermes's 13F filing for Q2 2019, filed 14 Aug 2019.